Recent Clinical Advances of the Use of Three Kinds of Laser Systems Combined with a New Exosome-Based Postlaser Booster Solution
<b><i>Background:</i></b> The major challenge in cosmetics is the ability of functional ingredients to penetrate the skin barrier. For this reason, "skin boosters" have been developed, indicating a change from the traditional application of hyaluronic acid (HA) fillers, which had been confined to increasing the volume of the skin, to a more diversified use designed to relieve dermal complications. <b><i>Methods:</i></b> Thirty subjects (aged between 31 and 83 years and Fitzpatrick skin types II-IV) with skin irregularities as mild wrinkles or pigmented lesions were enrolled. Patients were treated on the one side with laser and a medical repairing ointment, and on the other side with laser and postlaser exosomes booster solution. Different laser procedures were used (Q-switched laser, CO<sub>2</sub> laser, 675 nm nonablative laser). To analyze the effect on postprocedure laser management, patients were monitored before treatment, immediately after, 1 h after, 3 days after, and 30 days after with the imaging system. <b><i>Results:</i></b> All the patients treated did not show any significant side effects apart from the redness. The side of the face treated with laser and medical repairing ointment showed a more intense redness than the side treated with laser and postlaser booster solution, both immediately after and 1 h after the treatment. <b><i>Conclusions:</i></b> These data confirm that the use of the postprocedure laser booster solution helps in posttreatment management by reducing redness statistically significantly, thus allowing patients to return to everyday life in a shorter time.
Authors
- Daniel Ricardo Galimberti (ORCID: https://orcid.org/0009-0000-1605-3201)
- Irene Fusco (ORCID: https://orcid.org/0000-0001-7264-8808)
- Tiziano Zingoni (ORCID: https://orcid.org/0009-0008-8688-7787)
- Francesca Madeddu (ORCID: https://orcid.org/0009-0009-5386-7656)
- Carlo Colombo
- Giustino Gallo
Institutions
- Universidad del Salvador (AR)
- Leo Pharma (Australia) (AU)
- El.En. Group (Italy) (IT)
Publication Details
- Journal
- Photobiomodulation Photomedicine and Laser Surgery
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1177/15578550251362371
- Primary Topic
- Dermatologic Treatments and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00